Cinsel Hastalıklardan Korunma Yolları
Özet
Cinsel yolla bulaşan enfeksiyonlar (CYBE); korunmasız cinsel temas, enfekte kan transfüzyonları ve gebelik, doğum ya da emzirme sırasında anneden bebeğe geçiş yoluyla bulaşan küresel bir halk sağlığı sorunudur. Bakteriler, virüsler, mantarlar ve parazitler nedeniyle ortaya çıkan bu hastalıklar sıklıkla asemptomatik seyretmekle birlikte; tedavi edilmediklerinde kısırlık, kanser ve ölü doğum gibi ciddi klinik sonuçlara yol açabilmektedir. En sık rastlanan türleri arasında kandidiyazis, klamidya, bel soğukluğu, frengi, genital herpes ve HIV/AIDS yer almaktadır. Enfeksiyonlardan korunmada tek eşlilik, partner geçmişinin bilinmesi ve cinsel birleşme boyunca kesintisiz kondom kullanımı birincil koruma yöntemleridir. Ayrıca HPV ve Hepatit B gibi yaygın viral ajanlara karşı aşılama, erkek sünneti ve diyafram kullanımı da bulaş riskini belirgin şekilde azaltmaktadır. Toplumsal farkındalığın artırılması, riskli grupların düzenli taranması ve erken teşhis, CYBE’nin yayılımını önlemede kritik öneme sahiptir.
Sexually transmitted infections (STIs) represent a major global public health challenge, transmitted via unprotected sexual contact, infected blood and blood products, or from mother to child during pregnancy, childbirth, or breastfeeding. Caused by a wide range of bacteria, viruses, fungi, and parasites, these infections are frequently asymptomatic but can lead to severe long-term complications such as infertility, cancer, and stillbirth if left untreated. Common STIs include candidiasis, chlamydia, gonorrhea, syphilis, genital herpes, and HIV/AIDS. The primary strategies for prevention include mutual monogamy, understanding sexual partner histories, and the consistent and correct use of condoms throughout sexual activity. Additionally, immunization against highly prevalent viral pathogens like HPV and Hepatitis B, male circumcision, and the use of vaginal diaphragms significantly decrease transmission rates. Enhancing public awareness, implementing routine screening for high-risk populations, and ensuring early clinical diagnosis are absolutely vital to controlling the spread of STIs.
Referanslar
World Health Organization. Data and Statistics. Available from: http://www.who.int/hiv/data/en/
U.S. Statistics. Fast Facts. Available from: https://www.hiv.gov/hiv-basics/overview/data-andtrends/statistics
Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187-93.
Sağlık Bakanlığı Halk Sağlığı Genel Müd. Bulaşıcı Hastalıklar Daire Başk. Available from: http://www.thsk.gov.tr/component/k2/353-istatikselveriler/bulasici-hastaliklar-daire-baskanligi istatikselveriler.html?highlight=YToxOntpOjA7czozOiJoaXYiO30
Türkiye Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Bulaşıcı Hastalıklar Dairesi Başkanlığı. HIV-AIDS İstatistik. Available from: https://hsgm.saglik.gov.tr/tr/bulasici-hastaliklar/862-hivaids.html
Scott-Sheldon LAJ, Chan PA. Increasing sexually transmitted infections in the U.S.: A call for action for research, clinical, and public health practice. Arch Sex Behav. 2020;49,13–17.
World Health Organization. Sexually Transmitted Infections (STIs). 2016. Available from: http://www.who.int/news-room/fact-sheets/detail/sexuallytransmitted-infections-(stis)
Hughes G, Catchpole M, Rogers PA, Brady AR, Kinghorn G, Mercey D, et al. Comparison of risk factors for four sexually transmitted infections: results from a study of attenders at three genitourinary medicine clinics in England. Sex Transm Infect. 2000;76(4):262–7.
Medina-Perucha L, Family H, Scott J, Chapman S, Dack C. Factors associated with sexual risks and risk of STIs, HIV and other blood-borne viruses among women using heroin and other drugs: A systematic literature review. AIDS Behav. 2019; 23(1): 222–51.
Adams J, Moody H, Morris M. Sex, drugs, and race: How behaviors differentially contribute to the sexually transmitted infection risk network structure. Am J Public Health. 2013;103(2): 322–29.
Akbarzadeh M, Bonyadpoure B, Pacshir K, Mohagheghzadeh A. Causes and clinical symptoms of vaginal candidiasis in patients referring to selective clinics of Shiraz University of Medical Sciences. Arak University of Medical Sciences Journal. 2009;13(3):12–20.
Bouchemal K, Bories C, Loiseau PM. Strategies for prevention and treatment of trichomonas vaginalis infections. Clin Microbiol Rev. 2017;30(3):811–25.
Eschenbach DA. Bacterial vaginosis: resistance, recurrence, and/or reinfection? Clin Infect Dis. 2007;44(2):2201.
O’Connell CM, Ferone ME. Chlamydia trachomatis genital infections. Microb Cell. 2016;3(9): 390–403.
Unemo M. Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis. 2015;15:364.
Sauerbrei A. Optimal management of genital herpes: current perspectives. Infect Drug Resist. 2016;9:129–41.
Golden MR, Marra CM, Holmes KK. Update on Syphilis. JAMA. 2003;290(11):1510.
González-Beiras C, Marks M, Chen CY, Roberts S, Mitjà O. Epidemiology of Haemophilus ducreyi Infections. Emerg Infect Dis. 2016;22(1):1–8.
Altınyazar HC. Lenfogranüloma Venorum. Turkiye Klinikleri J Dermatol-Special Topics. 2014;7(1):33-5.
Uslu E, Aliağaoğlu C. Granuloma Inguinale. Turkiye Klinikleri J Dermatol-Special Topics. 2014;7(1):36-9.
Kumbak Aygün B, Çelik H, Kavak B, Gürateş B. Kondiloma aküminata ve tedavi yöntemleri. Türk Jinekolojik Onkoloji Dergisi 2009;12(2):29-34.
Yorulmaz A, Metin A, Doğan S. Molluskum Kontagiozum. Turkiye Klinikleri J Dermatol-Special Topics. 2014;7(1):67-74.
Li HC, Lo SY. Hepatitis C virus: Virology, diagnosis and treatment. World J Hepatol. 2015;7(10):1377-89.
EASL 2017 Clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370-98.
Kara İH. Akut viral hepatit B. Türk Aile Hek Derg. 2008;12(1):39-43.
Erbay A, Kayaaslan B, Akıncı E, Öngürü P, Eren SS, Gözel G, et al. Evaluation of epidemiological, clinical and laboratory features of HIV/AIDS Cases. FLORA. 2009;14(1):36-42.
Aslan FG, Altındiş M. HIV’in güncel tanı algoritmi ve gelişen korunma yöntemleri. Türk Mikrobiyol Cem Derg 2017;47(2):47-60.
LeFevre ML. USPSTF: Behavioral counseling interventions to prevent sexually transmitted infections. Ann Intern Med. 2014;161(12):894–901.
Lin JS, Whitlock E, O’Connor E, Bauer V. Behavioral counseling to prevent sexually transmitted infections: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149(7):497–508.
Mayaud P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sexually Transmitted Infections. 2004,80(3):174–182.
Shain RN, Perdue ST, Piper JM, Holden AE, Champion JD, Newton ER, et al. Behaviors changed by intervention are associated with reduced STD recurrence: the importance of context in measurement. Sex Transm Dis. 2002;29(9):520–9.
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(2):1–24.
Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007;85(9):719–26.
Paavonen J, Jenkins D, Bosch FX, Naud P, Salmerón J, Wheeler CM, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet. 2007;369(9580):2161–70.
Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Morb Mortal Wkly Rep. 2007;56(42):1114.
Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(7):1–23.
Halliday J, Klenerman P, Barnes E. Vaccination for hepatitis C virus: closing in on an evasive target. Expert Rev Vaccines. 2011;10(5):659–72.
Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, van Griensven F, et al. Randomized, doubleblind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 2006;194(12):1661–71.
Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, et al. HIV vaccine research: the way forward. Science 2008; 321(5888):530–2.
Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis. 2002;29(11):725–35.
Ness RB, Randall H, Richter HE, Peipert JF, Montagno A, Soper DE, et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health. 2004;94(8):1327–9.
Grau, LE, White E, Niccolai LM, Toussova OV, Verevochkin SV, Kozlov AP, et al. HIV disclosure, condom use, and awareness of HIV infection among HIV-Positive, heterosexual drug injectors in St. Petersburg, Russian Federation. AIDS Behav. 2011;15:45–57.
Paz-Bailey G, Koumans EH, Sternberg M, Pierce A, Papp J, Unger ER, et al. The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med. 2005;159(6):536–42.
Niccolai LM, Rowhani-Rahbar A, Jenkins H, Green S, Dunne DW. Condom effectiveness for prevention of Chlamydia trachomatis infection. Sex Transm Infect. 2005;81(4):323–5.
Minnis AM, Padian NS. Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions. Sex Transm Infect. 2005;81(3):193–200.
Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med. 2009;360(13):1298–309.
Ramjee G, van der Straten A, Chipato T, de Bruyn G, Blanchard K, Shiboski S, et al. The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLoS One. 2008;3(10):3488.
Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines. MMWR Recomm Rep. 2010;59(12):1–110.
US Preventive Services Task Force. Behavioral counseling to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(7):491.
